Putting the theory of personalised medicine into practice
Putting the theory of personalised medicine into practice
Personalised cancer medicine and research: Today’s best practice
Phase III trial shows crizotinib superior to single-agent chemotherapy for ALK-positive lung cancer
Key topics from day 2 of the 10th International Workshop on Non-Hodgkin's Lymphoma
Molecular stratification of breast cancer: reaching the clinic
The ceRNA Hypothesis and the non-coding revolution in cancer research and therapy
Australia Pancreatic Cancer Genome Initiative
Potential for micro-RNA based cancer treatments
Bevacizumab benefits beyond progression in TML study subgroups
Translational and tailored, but can we afford it?
Translational and tailored, but can we afford it?
Cost efficiency of targeted therapy